Liquid Biopsy Tests for Cancer

JAMA Clinical Reviews by American Medical Association

Aug 10, 202623:48Health

Circulating tumor DNA (ctDNA)(liquid biopsies) can help monitor cancer progression, detect residual cancer after treatment, and identify genetic changes within cancer cells that could affect treatment response. Author Be...

Related Episodes

Continue listening to more episodes from JAMA Clinical Reviews.

Vaccines for Cancer Treatment

Sep 21, 2026 - 20:12

Cancer vaccines stimulate immune cells to recognize proteins or mutations found on or within cancer cells...

Idiopathic Normal Pressure Hydrocephalus: Diagnosis and Treatment

Sep 14, 2026 - 19:14

Idiopathic normal pressure hydrocephalus (iNPH) affects approximately 1% to 4% of adults aged 65 years an...

Rheumatoid Arthritis

Sep 10, 2026 - 23:15

Rheumatoid arthritis can affect any synovial joint and cause irreversible damage, but early diagnosis and...

An Overview of Postural Orthostatic Tachycardia Syndrome (POTS)

Aug 24, 2026 - 28:43

POTS is a chronic autonomic disorder characterized by excessive orthostatic tachycardia and multisystem s...

Medication Treatments for Alcohol Use Disorder

Aug 19, 2026 - 20:14

Naltrexone, acamprosate, disulfiram, and topiramate are effective but underused medications for treatment...

Patient-Clinician Communication About Physical Activity

Aug 6, 2026 - 10:35

Physical activity is an effective component of care for people with chronic medical conditions. In this p...

Classic Hodgkin Lymphoma

Aug 3, 2026 - 20:59

Hodgkin lymphoma is a relatively rare disease, with approximately 82 409 incident cases reported globally...

The Sleep-Weight Connection

Jul 29, 2026 - 13:59

Suboptimal sleep quality and quantity are associated with higher body mass index and more difficulty losi...